baber/WOPTO huggingface dataset:
Patent JP-2001520848-A (JP)
IPC: H04R7/12
Filed: 1999-02-04
Abstract: An electroacoustic transducer (1) having a voice coil (17) and having a diaphragm (19) with an annular intermediate zone (22) for securing the voice coil (17), the intermediate zone (22) having angularly spaced-apart trough portions (29) which are each bounded by a trough bottom wall (30) and two trough side walls (31, 32), and the voice coil (17) being secured to the trough bottom walls (30).
Patent JP-2001519029-A (JP)
IPC: H04W64/00
Filed: 1998-03-20
Abstract: The invention relates to a system to be used as an aid in navigation comprising a mobile terminal (1, 2) connected to a centralized server (5), and more specifically to the improvements required to convert a portable radiotelephone (1) into a complete and precise navigational aid system. The invention is characterized by the fact that the itinerary requests of the mobile terminal (1, 2) are transmitted to a centralized server (5) by a radio relay link, and by the fact that the server (5), which contains the necessary cartographic and program data, calculates the itinerary requested and transmits to the mobile terminal (1, 2) the data concerning the straight line and arc segments that constitute the itinerary, thereby permitting real-time guidance. The invention is further characterized by the fact that the server (5) evaluates the possibility of the craft deviating from its course, as well as by the fact that the server (5) also calculates and transmits the data concerning the segments of possible deviation itineraries in an area of proximity to the main itinerary. The invention can be applied in particular to automotive vehicles.
Patent JP-2001525711-A (JP)
Title: 高キンク抵抗性を有するカテーテルシステム
IPC: A61M25/00
Filed: 1998-05-25
Abstract: (57)【要約】
生体内に対象物（８）を導入するためのデリバリー・キットの一部として使用できるカテーテルシステム（１）を提供する。本発明のカテーテルシステム（１）は、非常に高い可撓性およびキンク抵抗性とを同時に具備し、このため圧縮力および引張力を確実に伝達できる。カテーテルシステム（１）は、長手方向に延びている少なくとも１つの内側カテーテル（４）と、該内側カテーテルの周囲で内側カテーテル（４）の遠位端領域に配置された少なくとも１つのアクセサリ部品（６、１０）とを有する。カテーテルシステム（１）は更に管状要素（９）を有し、該管状要素（９）は、その少なくとも一方の端面が内側カテーテル（４）上に緊密に嵌合され、該端面は、内側カテーテル（４）の長手方向部分に対するアクセサリ部品（１０）の移動が防止されるように、アクセサリ部品（１０）の少なくとも一部と衝合する。
Patent JP-2000516687-A (JP)
Title: 燃料噴射装置
IPC: F02M61/18
Filed: 1999-03-27
Abstract: (57)【要約】
内燃機関、特に２サイクルディーゼルエンジンの燃料噴射装置であって、対応する燃焼室に突き出る偏心噴射ノズルチップ（４）を備えるものにおいて、前記ノズルチップは、燃料に影響を与えることのできる複数の外側に延びる燃料ノズルドリル孔（１３）を備えたポケット状のドリルホール（３）を有している。少なくとも、前記ドリルホール列の外側ノズルチップドリル孔（１３）の軸は、半径方向の展開に対して内側に向けられている。燃料進入における状態は、安定した噴射の結果として全てのノズルドリル孔（１３）において略同じである。進入チャンバ（１６）は、ポケット状のドリルホール（３）から離れており、かつノズルドリル孔（１３）の少なくとも一つの部分に設けられている。それにより、チャンバの内径は、ノズルドリル孔（１３）の直径よりも大きく、かつ前記チャンバは、少なくとも同様な長さ比がドリル孔列に全てのノズルドリル孔（１３）に対して存在するように設けられている。
Patent MX-151498-A (MX)
Inventor: KUBBELER HANS KLAUS
IPC: C07C17/18
Filed: 1981-08-31
Abstract: The invention relates to the production of anhydrous alkyl iodides. To this end, carboxylic acid alkyl esters of the formula R1COOR2, in which R1 stands for hydrogen or an alkyl or aryl radical having from 1 to 8 carbon atoms and R2 stands for an alkyl group having from 1 to 4 carbon atoms, are reacted with iodine and hydrogen and optionally with carbon monoxide in the presence of compounds of noble metals comprised of rhodium, iridium, palladium or ruthenium as catalyst, and of a heterocyclic aromatic compound, in which at least one hetero atom is a quaternary nitrogen atom, or of a quaternary organophosphorus compound as a promoter, and optionally also in the presence of a carboxylic acid having from 1 to 8 carbon atoms and/or its anhydrides. The reaction is effected under practically anhydrous conditions at temperatures of from 350 to 420 K. and under a total pressure of up to 30 bars.
Patent NZ-182752-A (NZ)
Title: Laser welding of sheet layers
Inventor: OSBORNE R
IPC: B23K26/067
Filed: 1976-11-29
Abstract: Thermoplastic materials, particularly material in sheet form, may be sealed or thermowelded together using the energy from a single laser beam source by splitting the beam and directing it by mirrors to desired seal areas on the opposed sides of the materials to be sealed. The beam may be split in proportion to the thickness of the respective materials. Heating the opposed sides of materials to be sealed avoids the problem of overheating or burning the side to which energy is applied.
Patent NZ-192108-A (NZ)
Title: Tablet containing analgesic medicament and metoclopramide
Inventor: POYSER R
IPC: A61K31/165
Filed: 1979-11-13
Abstract: Analgesic tablets which comprise an analgesic Medicament and metoclopramide or an acid addition salt thereof, the weight ratio of analgesic to metoclopramide or acid addition salt thereof lying in the range of 50:1 to 250:1, and a process fortheir preparation.
Patent NZ-214542-A (NZ)
Title: Monoclonal antibodies and antigen for human non-small cell lung carcinomas
Inventor: HELLSTROM INGEGERD
IPC: C12N5/10
Filed: 1985-12-13
Abstract: The present invention is concerned with novel monoclonal antibodies which define a glycolipid antigen associated with human non-small cell lung carcinomas ("NSCLC") and certain other human carcinomas. The antibodies bind to normal human cells to a much lesser degree than to tumor cells. The antibodies find use in diagnostic methods such as the detection of malignant cells associated with NSCLC and in therapeutic methods. Also disclosed in a novel glycolipid antigen. The invention also comprises a method for determining the presence of a malignant condition in lung tissue and other human tissue. The method involves examining the human tissue for the presence of a glycolipid antigen having the terminal carbohydrate sequence: GalNAc beta l->4Gal beta l->3GalNAc beta l->4Gal beta l->R.
Patent NZ-220511-A (NZ)
Title: Preparation of l-tertiary leucine and l-phosphino-thricine by transamination; and microorganisms used therein
Inventor: THEN JOHANN
IPC: C12N1/21
Filed: 1987-06-02
Abstract: Prodn. of L-tert.-leucine (Ia) or L-phosphinothricin (Ib) is effected by tranamination of 3,3-dimethyl-2-oxobutyric acid (IIa) or (3-carboxy-3-oxopropyl)methylphosphinic acid (IIb), or their salts, with an amino acid (III) as amino gp. binder. Pref. the reaction is effected in the presence of a transaminase enzyme at pH 7-8.5 using a (III):(II) ratio of 1-5:1, esp. 1-2:1. The enzyme is used in pure form, in the form of a microorganism, or in the form of a cell extract or protein isolate derived from a microorganism. The microorganism is a Paracoccus, Alcaligenes, Pseudomonas, Serratia, Agrobacterium, Streptomyces or Enterbacterium strain, or a genetically manipulated microorganism, esp. E.coli ATCC 11303 transformed with a plasmid contg. a tyrB or 1lvE gene.
Patent NZ-221013-A (NZ)
Title: Transdermal device includes an electrical source and two electrodes
Inventor: BANNON YVONNE BRIGID
IPC: A61N1/30
Filed: 1987-07-09
Abstract: A disposable electrode (3) for use in a transdermal device comprises a first surface adapted for contact with human skin and through which a drug substance contained in the electrode passes to the skin under the influence of an iontophoretic or electro-osmotic force and a second surface (4) which is electrically conducting, the electrode has a surface area in contact with the skin, in use, in the range 0.1 to 30 cm<2> and a drug dissolved or dispersed in a hydrophilic medium (5) at a concentration in the range 0.1 to 15% (w/v) based on the hydrophilic medium.
Patent NZ-224427-A (NZ)
Title: 2-phenoxy- and 2-pyridinyloxy-butyric acid anilides and herbicidal compositions
Inventor: MUNRO DAVID
IPC: C07C233/56
Filed: 1988-04-29
Abstract: A novel herbicide of formula I <CHEM> wherein R1 represents a halogen atom or an alkyl, haloalkoxy, haloalkyl or alkoxycarbonyl group;      R2 represents a hydrogen or halogen atom; each of R3 to R6 independently represents a hydrogen or halogen atom or a cyano, alkyl, haloalkyl, alkoxy or haloalkoxy group; R7 represents a hydrogen or halogen atom, or an alkyl, haloalkoxy, haloalkyl or alkoxycarbonyl group; and A represents a nitrogen atom or a -CH- group, together with its formulation and use as a herbicide, and its preparation.
Patent NZ-227233-A (NZ)
Title: Peelable polymeric laminated barrier film for vacuum skin packaging
Inventor: DAVIS KENT ALAN
IPC: B65D75/58
Filed: 1988-12-07
Abstract: Disclosed is a film (1) for forming vacuum skin packages which comprises a coextruded, multi-layer composite forming web comprising a gas permeable film (2) and a gas impermeable film (3) which can be manually delaminated from each other, the gas permeable film having a plurality of layers including a heat sealable, polymeric layer, and a layer comprising a linear ethylene/alpha-olefin copolymer having a density of less than 0.915 g/cc, the gas impermeable film having a plurality of layers including a barrier layer of a hydrolyzed ethylene/vinyl-acetate or vinylidene chloride copolymer the barrier layer being immediately adjacent to and in contact with the linear ethylene/alpha-olefin copolymer so that when the layers are peeled apart the barrier layer will become a first surface layer and, an outer or second surface layer of polymeric material: the heat sealable layer of the permeable film seals to the surface of the package support member with a bond strength greater than the force required to delaminate the permeable layer from the impermeable layer so that the permeable layer can be peeled from the impermeable layer leaving the package covered with a permeable layer so that oxygen can penetrate to the packaged product.
Patent NZ-230419-A (NZ)
Title: Polymeric compound derived from a polyhydric material and pendant sulphonate groups
Inventor: WADE JOHN ROBERT
IPC: C08F8/36
Filed: 1989-08-24
Abstract: A polymeric compound is derived from a polyhydric material and has pendant sulphonate groups of the general formula <CHEM> where X is an aliphatic, aromatic, carbocylic or heterocyclic group; Y is hydrogen, halogen or an alkyl, aryl, alkoxy, aryloxy or aralkyl group, CO2<->Z<+>, CO2R or SO3<->Z<+>; Z<+> is a cationic counter ion and R is hydrogen, alkyl, alkylene, aryl or aralkyl group.
Patent NZ-232484-A (NZ)
Title: Magnetic key operated lock with code changing wheels and magnet pins
Inventor: SEDLEY BRUCE SAMUEL
IPC: E05B47/00
Filed: 1990-02-12
Abstract: In a magnetic key operated lock, a slide member carries a plurality of wheels in which are mounted magnetic pins. The position of the pins forms part of a code of the lock. The wheels are caused to rotate by insertion of a code changing key, which has a code for unlocking the lock, and moving the slide member. As the slide member moves, one of the pins which is repelled by the particular code changing key abuts a stop, which thus causes the respective wheel, and so the other wheels, to rotate. By having wheels of two different diameters, the smaller wheels can be made to rotate more than once before a code is repeated. The stops are formed by pressing a tang from a stationary wall in the lock.
Patent NZ-235394-A (NZ)
Title: Method for protecting static-sensitive environments and packaging therefor made from polyurethane
Inventor: ROBERTS WILLIAM PEYTON
IPC: C08G18/66
Filed: 1990-09-20
Abstract: Packaging materials containing inherently antistatic foams and a method of using the foams are disclosed. The foam used is a polyether polyurethane foam prepared from an isocyanate containing prepolymer which is the reaction product of a oxyethylene containing polyol and a polyisocyanate. The foams show surface resistivity of less than 1 x 10<1><2> ohms/square and static decay times of about two seconds or less. A preferred foam shows static decay times of 0.1 seconds or less. The packaging includes articles used around static sensitive devices or used to store or transport static sensitive devices.
Patent NZ-235728-A (NZ)
Title: Substituted oxazoles, preparation and pharmaceutical compositions thereof
Inventor: JARREAU FRANCOIS-XAVIER
IPC: A61P25/20
Filed: 1990-10-17
Abstract: The derivatives of the formula:   <IMAGE> (I)  wherein: R1 is H or C1-C4 alkyl; X is an oxygen atom, a methylene group or a -CH=CH- group; n is 1 or 2 when X is an oxygen atom or a methylene group and is 0 or 1 when X is a -CH=CH- group; R3 is a C1-C4 alkyl, C3-C7 cycloalkyl, phenyl, benzyl, CHF2, CF3 or CF3CF2 group; each of R2 and R'2 independently is a hydrogen atom or a C1-C4 alkyl, C4-C7 cycloalkyl, phenyl or benzyl group; R'2 and R3 may further form together a -(CH2)3- or -(CH2)4- chain; and each of R4 and R'4 independently is a C1-C4 alkyl group or R4 and R'4 form together either a -(CH2)2- or -(CH2)3- chain, a -(CH2)2- or -(CH2)3- chain substituted by one or two C1-C4 alkyl groups, or a -(CH2)2- chain substituted by one or two -CH2-NH2 groups or by one or two -CH2-NH2 groups N-substituted by one or two C1-C4 alkyl groups, useful as drugs.
Patent NZ-254769-A (NZ)
Title: Lubricant and lubricant solution; based on fatty amines and contains at least one linear polyamine derivative of a fatty amine
Inventor: LAUFENBERG ALFRED
IPC: C10M133/04
Filed: 1993-07-26
Abstract: PCT No. PCT/EP93/01984 Sec. 371 Date Feb. 3, 1995 Sec. 102(e) Date Feb. 3, 1995 PCT Filed Jul. 26, 1993 PCT Pub. No. WO94/03562 PCT Pub. Date Feb. 17, 1994.Lubricant concentrates and aqueous lubricant solutions containing at least one polyamine derivative of a fatty amine and/or a salt of such an amine. The invention also relates to a process for the production of the lubricant concentrates and to the use of the lubricant concentrates and the aqueous lubricant solutions as chain lubricants in the food industry.
Patent NZ-255617-A (NZ)
Title: Tdma digital radio: measuring path loss and setting transmission power accordingly
Inventor: BODIN STIG ROLAND
IPC: H04B7/005
Filed: 1993-04-11
Abstract: In a telecommunications system, a method and system for power regulation compares the received power to a target value at a receiving station to adjust the power of the transmitting station periodically or non-periodically. Calculation of the signal strength required at the transmitting station may be performed at either the transmitting or receiving station using the path loss between the respective stations. The target value may be a constant or a function of the distance from the base station or a function of the path loss between the transmitting and receiving station.
Patent NZ-264067-A (NZ)
Title: Polyphenol (composition) from unripe fruits of rosaceae; use as antioxidant, antimutagenic, antiallergesic, anticariogenic or hypotensive agent
Inventor: TANABE MASAYUKI
IPC: A61K31/35
Filed: 1994-07-22
Abstract: The present invention provides a fruit polyphenol obtained by subjecting unripe fruits of Rosaceae to pressing and/or extraction and then purifying the resulting juice or extract. The present invention further provides an antioxidant, a hypotensive agent, an antimutagenic agent, an antiallergic agent and an anticariogenic agent each comprising, as an effective component, a fruit polyphenol obtained by subjecting unripe fruits of Rosaceae to pressing and/or extraction and then purifying the resulting juice or extract. The fruit polyphenol of the present invention has various physiological activities, for example, an antioxidative activity, an ACE-inhibiting activity, an antimutagenic activity, a hyalulonidase-inhibiting activity and a GTase-inhibiting activity. <IMAGE>
Patent NZ-294464-A (NZ)
Title: Stable, aqueous formulation having high biological alpha-type interferon activity buffered from 4.5 to 7.1 and comprising chelating agent and a polyoxyethylene sorbitan monooleate, formulation free from human blood-derived products
Inventor: YUEN PUI-HO C
IPC: A61K9/08
Filed: 1995-10-10
Abstract: Stable aqueous solution formulations containing alfa-type interferon, e.g., interferon alfa-2a and interferon alfa-2b, a buffer to maintain the pH in the range of 4.5-7.1, polysorbate 80 as a stabilizer, edetate disodium as a chelating agent, sodium chloride as a tonicity agent, and m-cresol as an antimicrobial preservative and which maintain high chemical, physical and biological stability of the alfa-type interferon for an extended storage period of at least 24 months are disclosed.
Patent NZ-334522-A (NZ)
Title: Lentiviral vectors with the absence of TAR (TAT responsiveness) sequence
Inventor: KINGSMAN ALAN JOHN
IPC: A61K35/76
Filed: 1997-10-17
Abstract: Retroviral vector particles capable of infecting and transducing non-dividing mammalian target cells, which vector particles may be based on lentiviruses such as HIV and which have an RNA genome constructed so as to provide in the DNA provirus a non-lentiviral expression control element in the 5'LTR of the provirus.
Patent NZ-335783-A (NZ)
Title: Skin prick test kit and method for determination of predisposition to periodontitis
Inventor: BLOMLOF LEIF
IPC: A61K49/00
Filed: 1997-11-20
Abstract: Skin prick test for the determination of the predisposition of an individual to develop marginal periodontitis, said kit comprising: (a) a first reagent containing a known quantity of a surface structure common to anaerobic Gram negative pathogens which is capable of triggering the inflammatory response associated with periodontitis and gingivitis; (b) second reagent containing an agonist to said individual; (c) a negative control; and (d) instructions for the use of said kit; and a method for such determination of predisposition.
Patent NZ-503896-A (NZ)
Title: Guide rails for fridge shelves to allow products to be placed in longitudinal lines
Inventor: LIM-YIP HONG
IPC: F25D25/02
Filed: 2000-04-11
Abstract: Alignment member 1 has elongate member 2. It is fitted to a wire grid having juxtaposed members 4 joined to each other by at least two members extending below members 4. Typically the grid is a refrigerator shelf. In situ, member 2 extends along the shelf so that products can engage member 2 and be arranged in line longitudinally on the shelf.
Patent NZ-504216-A (NZ)
Title: Use of unsubstituted polydiallylamines as bile sequestering agents to treat hypercholesterolemia
Inventor: PETERSEN JOHN S
IPC: A61P9/10
Filed: 1998-10-26
Abstract: Pharmaceutical composition comprising a polydiallylamine polymer or salts thereof, said polymer characterized in that the polymer is substantially free of alkylated amine monomers.
Patent NZ-508722-A (NZ)
Title: Prodrugs of dipeptidyl peptidase IV inhibitors, pharmaceutical compositions and uses thereof
Inventor: DEMUTH HANS-ULRICH
IPC: A61K45/00
Filed: 1999-06-24
Abstract: Prodrug compounds of inhibitors of dipeptidyl peptidase IV (DP IV), which prodrug compounds have the general formula A-B-C, where: A is an amino acid, B is a chemical bond between A and C or is an amino acid, and C is a stable inhibitor of DP IV without C-terminal phosphonate residue. Also described is a pharmaceutical composition, comprising at least one prodrug compound as described above, optionally in combination with customary carriers or excipients. The prodrug compounds described above are useful for temporally controlled in vivo inhibition of DP IV.
Patent NZ-508818-A (NZ)
Title: Electro-spinning process for making starch filaments for flexible structure
Inventor: GORDON GREGORY CHARLES
IPC: D04H1/4274
Filed: 2000-12-12
Abstract: A flexible structure comprises a plurality of starch filaments. The structure comprises at least a first region and a second region, each of the first and second regions having at least one common intensive property selected from the group consisting of density, basis weight, elevation, opacity, crepe frequency, and any combination thereof. The common intensive property of the first region differs in value from the common intensive property of the second region.
Patent NZ-508956-A (NZ)
Title: Conformationally constrained backbone cyclized somatostatin analogs
Inventor: HORNIK VERED
IPC: A61K49/00
Filed: 1999-06-15
Abstract: A backbone cyclized somatostatin analog incorporates at least one building unit that contains on nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester or disulfide. The building unit is connected via the bridging group form a cyclic structure with a moiety selected from the group consisting of a second unit, the side chain of an amino acid residue of the sequence or the N-terminal amino acid residue. Also described is a pharmaceutical composition comprising the somatostatin analog which is useful in treating cancer, autoimmune diseases, endocrine disorders, diabetic-associated complications, gastrointestinal disorders, inflammatory diseases, pancreatitis, atherosclerosis, restenosis and post-surgical pain. The analog can also be used for diagnosing cancer and imagining the existence of metastases.
Patent NZ-513258-A (NZ)
Title: Tissue paper
Inventor: STEINHARDT MARK JOHN
IPC: A47K10/16
Filed: 2000-02-09
Abstract: A wiping implement suitable for use as a bath tissue can be formed into sheets, each sheet comprising at least one ply of a paper web having a basis weight of at least about 25 lb/3000 square feet. The sheet can have a width of at least about 4.5 inches and temporary wet tensile properties. The sheet of the present invention can have an area of at least about 30 square inches. In a multiple ply embodiment, the sheet can have an optimized basis weight of at least about 42 lb/3000 square feet while maintaining nearly the same amount of actual total fiber usage per cleaning task as current premium bath tissue.
Patent NZ-516660-A (NZ)
Title: PSCA: Prostate stem cell antigen for diagnosis and treatment of prostate cancer
Inventor: REITER ROBERT
IPC: G01N33/53
Filed: 1998-03-10
Abstract: An isolate Prostate Stem Cell Antigen protein consists of the amino acid sequence beginning with glycine at position 18 and ending with histidine at position 98 or beginning with leucine at position 21 and ending with alanine at position 99 according to SEQ ID NO:2 or consisting of the sequence TARIRAVGLLTVISK or VDDSQDYYVGKK. Also described are nucleic acid sequences encoding the proteins, a method for detecting a nucleic acid molecule encoding the protein in a sample and pharmaceutical compositions comprising the proteins. The protein can be used for inducing an immune response directed against a cell expressing a PSCA protein. An antibody or immunologically active fragment which binds the PSCA protein can be used fro inhibiting the growth of a cell or killing a cell expressing the PSCA protein.
Patent NZ-519326-A (NZ)
Title: 1,2-diarylbenzimidazoles for treating diseases that are associated with a microglia activation
Inventor: KUHNKE JOACHIM
IPC: A61P25/28
Filed: 2001-01-12
Abstract: 1,2-diaryl benzimidazoles of formula (I) and the use of these benzimidazole derivatives for producing medicaments utilized for the treatment and prophylaxis of illnesses that are associated with a microglia activation are disclosed, wherein the variables R1, R2, R3, A, B & Y are as described in the specification.
Patent NZ-521270-A (NZ)
Title: Altered strain of the Modified Vaccinia virus Ankara (MVA) for growth in a continuous vero cell line
Inventor: MAYR ANTON
IPC: A61K35/76
Filed: 2001-03-10
Abstract: A Modified Vaccinia Virus Ankara adapted for growing in a Vero cell line (Vero-MVA) obtained by a process comprising the following steps: a) infecting cells of the Vero cell line with a wild-type MVA; b) harvesting of the viruses produced from cells; and optionally c) infecting fresh cells of the Vero cell line with the newly produced viruses and harvesting the virus produced from the said cell.  This is repeated until the virus is adapted to growing in the cells. A method for producing a nucleic acid sequence, peptide and/or polypeptide, comprising: a) infection of a host cell with the recombinant Vero-MVA; b) cultivation of the infected host cell under suitable conditions; and optionally c) isolation and/or enrichment of the nucleic acid sequence, peptide and/or protein produced by said host cell. The Modified Vaccinia Virus Ankara (MVA) have a strongly reduced virulence for most mammals, especially humans.  The adapted MVA can be used e.g. for parenteral immunization, as a vector system, or in the active or inactivated from as an adjuvant or as a regulator of the unspecific components of the immune system.